antineoplastic agents

Aspraginaz-L (L-Asparaginase Injection) is an anticancer medicine containing L-Asparaginase, an enzyme used as part of combination chemotherapy for the treatment of certain blood cancers, particularly Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LBL). It works by breaking down the amino acid L-asparagine, which leukemia cells need for growth and survival. By depleting this essential amino acid, the injection helps stop the growth of cancer cells while allowing normal cells to recover. Key Benefits Helps treat Acute Lymphoblastic Leukemia (ALL). Used in the management of Lymphoblastic Lymphoma (LBL). Reduces the growth and spread of leukemia cells. Commonly administered as part of multi-drug chemotherapy regimens. Suitable for both pediatric and adult patients when prescribed by an oncologist. How It Works L-Asparaginase destroys circulating L-asparagine, an amino acid required by certain leukemia cells. Since these cancer cells cannot produce enough asparagine on their own, they stop growing and eventually die, while healthy cells can usually synthesize the amino acid and are less affected. Administration Administered by a qualified healthcare professional. Given as an intravenous (IV) or intramuscular (IM) injection. Dosage and treatment schedule depend on the patient's condition, age, body surface area, and chemotherapy protocol. Regular monitoring of liver function, pancreatic enzymes, blood glucose, and clotting parameters is recommended during treatment. Possible Side Effects Some patients may experience: Allergic or hypersensitivity reactions Nausea and vomiting Fever Skin rash Elevated blood sugar levels Liver function abnormalities Pancreatitis Bleeding or blood clotting disorders Seek immediate medical attention if severe allergic reactions, breathing difficulty, severe abdominal pain, or unusual bleeding occur